Adcock Ingram Integrated Report 2018

AEROTON Manufacturing facility: CAPACITY PER ANNUM 33 million large volume parenterals 35 million small volume parenterals PURPOSE The Critical Care facility produces intravenous fluids, blood collection bags, renal dialysis products and small- volume parenterals. BOOK VALUE R342 million (2017: R367 million) property, plant and equipment ACCREDITATIONS South Africa (SAHPRA), and Kenya (PPB) CAPACITY UTILISATION 100% BANGALORE Manufacturing JV facility: PURPOSE This facility produces tablets and capsules as a contract manufacturer for various pharmaceutical companies. BOOK VALUE R154 million (2017: R168 million) property, plant and equipment CAPACITY PER ANNUM 3.5 billion Tablets and capsules CAPACITY UTILISATION 90% ACCREDITATIONS UK (MHRA), Australia (TGA), South Africa (SAHPRA), France (ANSM), Tanzania (TFDA), Ghana (FDB), Namibia (NMRC), Kenya (PPB), Uganda (UNDA), Ethiopia (FMHACA), Zimbabwe (MCAZ), Malawi (PMPB), and Nigeria (NAFDAC). PROGRESS DURING THE YEAR The manufacturing building (Unit 2) adjacent to the current factory, was acquired in July 2018. Construction will begin in the first quarter of the 2019 financial year and the entire capital expenditure of INR160 million will be funded from internal cash resources in the joint venture. 4 million pour bottles 1 million Blood collection bags ADCOCK INGRAM  Integrated Report 2018 33